Dig a little deeper into what we've discussed in the past.
Opioids & Addiction: A Public-Health Approach to Change
Trend data on overdose deaths and judicial proceedings show the tragedy of the opioid crisis, its blight on rural and urban America and the failure to resolve it. Where initiatives have made a positive difference, they include a bundle of evidence-based public health, criminal justice and policy actions. The panel of experts addressed the core of a public-health approach to changing the trends in addiction, incarceration and death from opioids.
Thomas H. Carr, Executive Director of the Office of National Drug Control Policy’s (ONDCP) Washington/Baltimore High Intensity Drug Trafficking Area (HIDTA) Program
Jennifer L. Martin, J.D., M.A., Deputy Commissioner: Population Health and Disease Prevention at the Baltimore City Health Department
Developing Performance Management Systems for Public-Private Partnerships
Public-private arrangements are increasingly used to address large and complicated endeavors. Managing the performance of these initiatives, however, requires special technical and managerial tools. This dialogue brought together an Italian expert on such performance management systems with experts at the federal and state levels in the U.S. Our U.S. experts used real estate as the focus for their comments.
Carmine Bianchi, Ph.D., Professor of Business and Public Management, University of Palermo
Steve Cassard, Director of Special Projects, Maryland Economic Development Corporation
Robert Helwig, J.D., Installations, Housing and Utilities Privatization, Office of the Secretary of Defense (2000-14)
The Opioid Addiction Epidemic: Causes, Consequences and Treatments
Pain management and the promotion of prescription medicines led many patients to addiction and the nation to a crisis in managing it. Public- and private-sector experts held an interactive and in-depth discussion of the opioid crisis, sharing insights into lessons learned and next steps followed by an audience Q&A.
Lorena de Leon, MBA, director, National Clinical Programs, OPTUMCare
Kimberly A. Johnson, Ph.D., director, Center for Substance Abuse Treatment, SAMHSA
Yngvild Olsen, M.D., M.P.H., FASAM, medical director, Institutes for Behavior Resources Inc/REACH Health Services, ASAM
Cybersecurity: Is Patient Privacy Extinct?
Lessons Learned for Secure, Reliable Public-Private Systems
Privacy breaches to electronic health records and related financial data are happening faster and more frequently than ever. Recently, a breach at a major provider gave unauthorized access to the personal health information of 78.8 million. In light of this and other disturbing developments in the realm of health care privacy, academic and public- and private sector experts led an interactive and in-depth discussion about patient privacy, discussing the issue as it relates to the interaction between public-sector laws and private-sector initiatives and offering insight into lessons learned and next steps.
Kirk Grothe, CEO, Livanta
Charles Tumosa, professor of the practice in the School of Criminal Justice at the University of Baltimore
Public-Private Partnerships in an Age of Austerity: State-Local and Federal-State Dynamics
The Rosenberg Dialogue Series explores opportunities for the private sector to work in partnership with the public and nonprofit (nongovernmental organization) sectors to create a vibrant and economically strong society. This dialogue delves into how federalism and intergovernmental relations influence the type and extent of such partnerships.
John Callahan, executive in residence and program director, UB College of Public Affairs, School of Health and Human Services
John Willis, executive in residence, UB College of Public Affairs, School of Public and International Affairs
Maryland Hospitals and Environmental Sustainability: Green Health-Care Facilities
Health care is a vital component of Maryland's economy, but health-care facilities face many worksite and environmental challenges. Economic, social and environmental health impacts of energy consumption; water usage; material purchase, use and wastage; as well as the quantity and toxicity of the chemicals used in and for health care must be managed concurrently.
For health-care providers, there is also a moral imperative—an ethical obligation—to create a resilient health-care system that benefits citizens as well as organized stakeholders. Achieving this balance within resource constraints requires management efficiency, operational effectiveness, cost containment while maintaining quality of care, and ensuring employees' health, general safety and environmental sustainability.
How can these goals be achieved affordably and reliably? What are the opportunities for public-private-sector collaboration?
Joan Plisko, technical director, Maryland Hospitals for a Healthy Environment
Clifford Mitchell, director, Environmental Health Bureau, Prevention and Health Promotion Administration, Maryland Department of Health and Mental Hygiene
Access to Pharmaceutical Products and Services for Underserved Populations: Public- and Private-Sector Roles in the United States and India
The front line of our public health system is not a doctor's office, an emergency room or even a clinic, but our local pharmacies. The community pharmacist is the first and often most frequent point of contact that many people have with the organized health-care system. Medicine shortages are the most visible consequence of a changed and interconnected world, but underserved populations confront unmet needs for access to pharmacist services and clinical information.
Education for community pharmacists' clinical roles continues to require significant curricular change and mentored experiential education. This has led to an undersupply of pharmacists globally, with implications for unmet medical needs and avoidable drug interactions that manifest in other areas of the health-care system: crisis visits to emergency rooms; hospitalizations; and secondary, perhaps chronic, disabilities.
Magaly Rodriguez de Bittner, professor and chair, Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy
Anne Y.F. Lin, dean, School of Pharmacy, Notre Dame of Maryland University
Prasada Reddy, pharmacist, Taastrup Apotek, Copenhagen area, Denmark; Tamil Nadu Dr. M.G.R. Medical University; RMES's College of Pharmacy